Literature DB >> 22508840

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Robert S Rosenson1, H Bryan Brewer, W Sean Davidson, Zahi A Fayad, Valentin Fuster, James Goldstein, Marc Hellerstein, Xian-Cheng Jiang, Michael C Phillips, Daniel J Rader, Alan T Remaley, George H Rothblat, Alan R Tall, Laurent Yvan-Charvet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22508840      PMCID： PMC4159082          DOI： 10.1161/CIRCULATIONAHA.111.066589

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  144 in total

1.  Cellular localization and trafficking of the human ABCA1 transporter.

Authors:  E B Neufeld; A T Remaley; S J Demosky; J A Stonik; A M Cooney; M Comly; N K Dwyer; M Zhang; J Blanchette-Mackie; S Santamarina-Fojo; H B Brewer
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

2.  Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive.

Authors:  T Oka; T Kujiraoka; M Ito; T Egashira; S Takahashi; M N Nanjee; N E Miller; J Metso; V M Olkkonen; C Ehnholm; M Jauhiainen; H Hattori
Journal:  J Lipid Res       Date:  2000-10       Impact factor: 5.922

3.  Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.

Authors:  G Lambert; N Sakai; B L Vaisman; E B Neufeld; B Marteyn; C C Chan; B Paigen; E Lupia; A Thomas; L J Striker; J Blanchette-Mackie; G Csako; J N Brady; R Costello; G E Striker; A T Remaley; H B Brewer; S Santamarina-Fojo
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

4.  Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice.

Authors:  K Alam; R S Meidell; D K Spady
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

Review 5.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.

Authors:  M Krieger
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

6.  Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

Authors:  P Costet; Y Luo; N Wang; A R Tall
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

7.  LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.

Authors:  M E Brousseau; R D Kauffman; E E Herderick; S J Demosky; W Evans; S Marcovina; S Santamarina-Fojo; H B Brewer; J M Hoeg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

8.  A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits.

Authors:  H Okamoto; F Yonemori; K Wakitani; T Minowa; K Maeda; H Shinkai
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

9.  Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.

Authors:  R van Haperen; A van Tol; P Vermeulen; M Jauhiainen; T van Gent; P van den Berg; S Ehnholm; F Grosveld; A van der Kamp; R de Crom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

10.  LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.

Authors:  B A Laffitte; J J Repa; S B Joseph; D C Wilpitz; H R Kast; D J Mangelsdorf; P Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205
View more
  324 in total

1.  Clinical trials of HDL cholesterol-raising therapy: what have we learned about the HDL hypothesis from AIM-HIGH?

Authors:  Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

2.  Psoriasis: it's more than just the skin.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

3.  HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Authors:  Mark S Borja; Kit F Ng; Angela Irwin; Jaekyoung Hong; Xing Wu; Daniel Isquith; Xue-Qiao Zhao; Bryan Prazen; Virginia Gildengorin; Michael N Oda; Tomáš Vaisar
Journal:  J Lipid Res       Date:  2015-08-07       Impact factor: 5.922

4.  ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15(S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation.

Authors:  Sivareddy Kotla; Nikhlesh K Singh; James G Traylor; A Wayne Orr; Gadiparthi N Rao
Journal:  Free Radic Biol Med       Date:  2014-08-23       Impact factor: 7.376

Review 5.  Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL.

Authors:  Patrick M Hutchins; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

Review 6.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

7.  AIBP protects against metabolic abnormalities and atherosclerosis.

Authors:  Dina A Schneider; Soo-Ho Choi; Colin Agatisa-Boyle; Laurence Zhu; Jungsu Kim; Jennifer Pattison; Dorothy D Sears; Philip L S M Gordts; Longhou Fang; Yury I Miller
Journal:  J Lipid Res       Date:  2018-03-20       Impact factor: 5.922

Review 8.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

9.  Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden.

Authors:  Yu Kataoka; Jordan Andrews; MyNgan Duong; Tracy Nguyen; Nisha Schwarz; Jessica Fendler; Rishi Puri; Julie Butters; Constance Keyserling; John F Paolini; Jean-Louis Dasseux; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

Review 10.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.